Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Cue Biopharma Inc.

    NASDAQ: CUE · Real-Time Price · USD
    0.71
    0.05 (8.40%)
    At close: Jun 24, 2025, 3:59 PM
    0.72
    1.43%
    After-hours: Jun 24, 2025, 07:34 PM EDT
    8.40%
    Bid 0.72
    Market Cap 53.85M
    Revenue (ttm) 7.99M
    Net Income (ttm) -40.58M
    EPS (ttm) -0.64
    PE Ratio (ttm) -1.12
    Forward PE -1.63
    Analyst Buy
    Ask 0.72
    Volume 860,186
    Avg. Volume (20D) 188,345
    Open 0.66
    Previous Close 0.66
    Day's Range 0.65 - 0.73
    52-Week Range 0.45 - 1.99
    Beta 1.42

    About CUE

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol CUE
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for CUE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    Cue Biopharma Inc. is scheduled to release its earnings on Aug 13, 2025, during market hours.
    Analysts project revenue of ... Unlock content with Pro Subscription

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    2 months ago
    +5.35%
    Cue Biopharma shares are trading higher. Citizens ... Unlock content with Pro Subscription
    2 months ago
    -17.67%
    Cue Biopharma shares are trading lower. The company reported FY24 financial results.
    news image

    1 month ago · zacks.com

    Cue Biopharma, Inc. (CUE) Reports Q1 Loss, Misses Revenue Estimates

    Cue Biopharma, Inc. (CUE) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to loss of $0.25 per share a year ago.

    news image

    1 month ago · zacks.com

    Will Cue Biopharma, Inc. (CUE) Report Negative Q1 Earnings? What You Should Know

    Cue Biopharma (CUE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    news image

    2 months ago · seekingalpha.com

    Cue Biopharma, Inc. (CUE) Business Update Call (Transcript)

    Cue Biopharma, Inc. (NASDAQ:CUE ) Business Update Call April 15, 2025 4:30 PM ET Company Participants Eric Ribner - LifeSci Advisors Dan Passeri - Chief Executive Officer Lucinda Warren - Chief Busine...

    news image

    2 months ago · zacks.com

    Cue Biopharma, Inc. (CUE) Reports Q4 Loss, Misses Revenue Estimates

    Cue Biopharma, Inc. (CUE) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to loss of $0.28 per share a year ago.

    Add to Watchlist